Synlett 2021; 32(02): 202-206
DOI: 10.1055/s-0040-1706548
cluster
Modern Heterocycle Synthesis and Functionalization

Rhodium(III)-Catalyzed C–H Activation: Annulation of Petrochemical Feedstocks for the Construction of Isoquinolone Scaffolds

a   Pfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, USA
,
Dehuan Kong
b   BioDuro, No. 233 North FuTe Road, WaiGaoQiao Free Trade Zone, Shanghai 200131, P. R. of China
,
Wei Li
b   BioDuro, No. 233 North FuTe Road, WaiGaoQiao Free Trade Zone, Shanghai 200131, P. R. of China
,
a   Pfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, USA
,
a   Pfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, USA
,
Sylvie K. Sakata
a   Pfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, USA
,
Nicole Sun
b   BioDuro, No. 233 North FuTe Road, WaiGaoQiao Free Trade Zone, Shanghai 200131, P. R. of China
,
a   Pfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, USA
› Author Affiliations


Preview

This manuscript is dedicated to the memory ofProf. Keith Fagnou in celebration of his impact on the field of heterocycle synthesis and functionalization through metal-catalyzed C–H activation

Abstract

We describe a simple and robust procedure for the Rh(III)-catalyzed [4+2] cycloaddition of feedstock gases enabled through C–H activation. A diverse set of 3,4-dihydroisoquinolones and 3-methylisoquinolones have been prepared in good to excellent yields. The effects of using ethylene and propyne as coupling partners on C–H site selectivity have also been explored with a representative set of substrates and are discussed herein.

Supporting Information



Publication History

Received: 25 August 2020

Accepted after revision: 29 September 2020

Article published online:
05 January 2021

© 2021. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany